Korean Circ J.  2022 Mar;52(3):231-232. 10.4070/kcj.2021.0419.

Another Reason to Cut Down on Alcohol?

• Kim HC

• KMID: 2526957
• DOI: http://doi.org/10.4070/kcj.2021.0419

Abstract

No abstract available.

Reference

1. Meier P, Seitz HK. Age, alcohol metabolism and liver disease. Curr Opin Clin Nutr Metab Care. 2008; 11:21–26. PMID: 18090653.

2. Caputo F, Vignoli T, Leggio L, Addolorato G, Zoli G, Bernardi M. Alcohol use disorders in the elderly: a brief overview from epidemiology to treatment options. Exp Gerontol. 2012; 47:411–416. PMID: 22575256.

3. Rahman F, Kwan GF, Benjamin EJ. Global epidemiology of atrial fibrillation. Nat Rev Cardiol. 2014; 11:639–654. PMID: 25113750.

4. Csengeri D, Sprünker NA, Di Castelnuovo A, et al. Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes. Eur Heart J. 2021; 42:1170–1177. PMID: 33438022.

5. Larsson SC, Drca N, Wolk A. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. J Am Coll Cardiol. 2014; 64:281–289. PMID: 25034065.

6. Yang JH, Jeong JA, Kweon SS, et al. Causal association between alcohol consumption and atrial fibrillation: a mendelian randomization study. Korean Circ J. 2022; 52:220–230. PMID: 35129315.

7. Lawlor DA. Commentary: two-sample Mendelian randomization: opportunities and challenges. Int J Epidemiol. 2016; 45:908–915. PMID: 27427429.

8. Jeon C, Lee JY, Lee SJ, Jung KJ, Kimm H, Jee SH. Bilirubin and risk of ischemic heart disease in Korea: a two-sample Mendelian randomization study. Epidemiol Health. 2019; 41:e2019034–e2019030. PMID: 31319653.

9. Lee SH, Lee JY, Kim GH, et al. Two-sample mendelian randomization study of lipid levels and ischemic heart disease. Korean Circ J. 2020; 50:940–948. PMID: 32812402.

10. Drummond C, Hillyard M, Leonhardt M, et al. Comparison of European clinical guidelines on the management of alcohol use disorders. Eur Addict Res. 2021; 27:227–236. PMID: 33291106.